Literature DB >> 25929665

A longitudinal MRI study of cervical cord atrophy in multiple sclerosis.

Paola Valsasina1, Maria A Rocca, Mark A Horsfield, Massimiliano Copetti, Massimo Filippi.   

Abstract

There is an urgent need of fast and accurate methods for the longitudinal quantification of cervical cord atrophy in multiple sclerosis (MS). Aim of this study was to compare a new semi-automatic method [the active surface (AS) method] with an existing cord segmentation method (the Losseff method) to measure cervical cord atrophy progression in MS patients. Using the AS and Losseff methods, normalized cervical cord cross-sectional area (CSA) was compared between 35 MS patients and 9 healthy controls (HC) at baseline and after 2.3 years of follow-up. Correlations with clinical/conventional MRI variables and a power calculation study were also performed. At follow-up, the Losseff method detected a 1 % CSA increase in HC and a 3.5 % decrease in MS patients (p = 0.01), while the AS method detected a 0.1 % decrease in HC and 3 % decrease in MS patients (p = 0.02). The AS method was more sensitive to associations with disability/conventional MRI variables and also provided lower numbers of subjects per arm compared to the Losseff method in a putative clinical trial scenario. Cord AS CSA measurements were more sensitive to longitudinal changes in MS patients than Losseff measurements. Cord AS CSA might be a valuable surrogate outcome measure for monitoring neuroprotection in MS.

Entities:  

Mesh:

Year:  2015        PMID: 25929665     DOI: 10.1007/s00415-015-7754-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  34 in total

Review 1.  MRI of spinal cord in multiple sclerosis.

Authors:  Federica Agosta; Massimo Filippi
Journal:  J Neuroimaging       Date:  2007-04       Impact factor: 2.486

2.  A multicenter assessment of cervical cord atrophy among MS clinical phenotypes.

Authors:  M A Rocca; M A Horsfield; S Sala; M Copetti; P Valsasina; S Mesaros; V Martinelli; D Caputo; T Stosic-Opincal; J Drulovic; G Comi; M Filippi
Journal:  Neurology       Date:  2011-06-14       Impact factor: 9.910

3.  Improved MRI quantification of spinal cord atrophy in multiple sclerosis.

Authors:  Hugh Kearney; Marios C Yiannakas; Khaled Abdel-Aziz; Claudia A M Wheeler-Kingshott; Daniel R Altmann; Olga Ciccarelli; David H Miller
Journal:  J Magn Reson Imaging       Date:  2013-04-30       Impact factor: 4.813

4.  Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.

Authors:  Carsten Lukas; Dirk L Knol; Madeleine H Sombekke; Barbara Bellenberg; Horst K Hahn; Veronica Popescu; Katrin Weier; Ernst W Radue; Achim Gass; Ludwig Kappos; Yvonne Naegelin; Bernard M J Uitdehaag; Jeroen J G Geurts; Frederik Barkhof; Hugo Vrenken
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-06-27       Impact factor: 10.154

5.  A 3T MR imaging investigation of the topography of whole spinal cord atrophy in multiple sclerosis.

Authors:  J P Klein; A Arora; M Neema; B C Healy; S Tauhid; D Goldberg-Zimring; C Chavarro-Nieto; J M Stankiewicz; A B Cohen; G J Buckle; M K Houtchens; A Ceccarelli; E Dell'Oglio; C R G Guttmann; D C Alsop; D B Hackney; R Bakshi
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-28       Impact factor: 3.825

6.  Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial.

Authors:  X Lin; C R Tench; B Turner; L D Blumhardt; C S Constantinescu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

7.  Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions.

Authors:  N Evangelou; G C DeLuca; T Owens; M M Esiri
Journal:  Brain       Date:  2004-11-17       Impact factor: 13.501

8.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

9.  Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration.

Authors:  H Kearney; M A Rocca; P Valsasina; L Balk; J Sastre-Garriga; J Reinhardt; S Ruggieri; A Rovira; C Stippich; L Kappos; T Sprenger; P Tortorella; M Rovaris; C Gasperini; X Montalban; J J G Geurts; C H Polman; F Barkhof; M Filippi; D R Altmann; O Ciccarelli; D H Miller; D T Chard
Journal:  Mult Scler       Date:  2013-06-27       Impact factor: 6.312

10.  Primary progressive multiple sclerosis: a 5-year clinical and MR study.

Authors:  G T Ingle; V L Stevenson; D H Miller; A J Thompson
Journal:  Brain       Date:  2003-08-05       Impact factor: 13.501

View more
  10 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Intersubject Variability and Normalization Strategies for Spinal Cord Total Cross-Sectional and Gray Matter Areas.

Authors:  Nico Papinutto; Carlo Asteggiano; Antje Bischof; Tristan J Gundel; Eduardo Caverzasi; William A Stern; Stefano Bastianello; Stephen L Hauser; Roland G Henry
Journal:  J Neuroimaging       Date:  2019-09-30       Impact factor: 2.486

3.  Reliable volumetry of the cervical spinal cord in MS patient follow-up data with cord image analyzer (Cordial).

Authors:  Michael Amann; Simon Pezold; Yvonne Naegelin; Ketut Fundana; Michaela Andělová; Katrin Weier; Christoph Stippich; Ludwig Kappos; Ernst-Wilhelm Radue; Philippe Cattin; Till Sprenger
Journal:  J Neurol       Date:  2016-05-09       Impact factor: 4.849

4.  Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis.

Authors:  F X Aymerich; C Auger; J Alonso; M Alberich; J Sastre-Garriga; M Tintoré; X Montalban; A Rovira
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-28       Impact factor: 3.825

5.  Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study.

Authors:  Inga T Hagström; Ruth Schneider; Barbara Bellenberg; Anke Salmen; Florian Weiler; Odo Köster; Ralf Gold; Carsten Lukas
Journal:  J Neurol       Date:  2017-06-09       Impact factor: 4.849

6.  Considerations for Mean Upper Cervical Cord Area Implementation in a Longitudinal MRI Setting: Methods, Interrater Reliability, and MRI Quality Control.

Authors:  C Chien; V Juenger; M Scheel; A U Brandt; F Paul
Journal:  AJNR Am J Neuroradiol       Date:  2020-01-23       Impact factor: 3.825

Review 7.  The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis.

Authors:  Maria A Rocca; Giancarlo Comi; Massimo Filippi
Journal:  Front Neurol       Date:  2017-09-04       Impact factor: 4.003

Review 8.  Advances in spinal cord imaging in multiple sclerosis.

Authors:  Marcello Moccia; Serena Ruggieri; Antonio Ianniello; Ahmed Toosy; Carlo Pozzilli; Olga Ciccarelli
Journal:  Ther Adv Neurol Disord       Date:  2019-04-22       Impact factor: 6.570

9.  Heritability of cervical spinal cord structure.

Authors:  Linda Solstrand Dahlberg; Olivia Viessmann; Clas Linnman
Journal:  Neurol Genet       Date:  2020-02-26

10.  Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis.

Authors:  Antje Bischof; Nico Papinutto; Anisha Keshavan; Anand Rajesh; Gina Kirkish; Xinheng Zhang; Jacob M Mallott; Carlo Asteggiano; Simone Sacco; Tristan J Gundel; Chao Zhao; William A Stern; Eduardo Caverzasi; Yifan Zhou; Refujia Gomez; Nicholas R Ragan; Adam Santaniello; Alyssa H Zhu; Jeremy Juwono; Carolyn J Bevan; Riley M Bove; Elizabeth Crabtree; Jeffrey M Gelfand; Douglas S Goodin; Jennifer S Graves; Ari J Green; Jorge R Oksenberg; Emmanuelle Waubant; Michael R Wilson; Scott S Zamvil; Bruce A C Cree; Stephen L Hauser; Roland G Henry
Journal:  Ann Neurol       Date:  2022-01-04       Impact factor: 11.274

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.